Call Us + 33 1 84 88 31 00

Article R5125-46-1 of the French Public Health Code

The dispensing pharmacist may inform the operator, in particular via the emergency call centres or any equivalent system mentioned in article R. 5124-49-1, of supply shortages of the medicinal products which he supplies and of which he has not already been informed by the operator or by the Agence nationale de sécurité du médicament et des produits de santé and, if necessary, request an emergency supply.

Read More »

Article R5125-48 of the French Public Health Code

The pharmacist shall ensure that the conditions of transport are compatible with the proper storage of the medicinal products, products or articles mentioned in article L. 4211-1. He shall also ensure that all explanations and recommendations are made available to the patient.

Read More »

Article R5125-49 of the French Public Health Code

The carrier transports the medicinal products, products or articles mentioned in article L. 4211-1 under conditions which guarantee their perfect preservation; these medicinal products, products or articles cannot be stored and are delivered directly to the patient.

Read More »

Article R5125-50 of the French Public Health Code

The medicines, products or objects mentioned in article L. 4211-1 may only be dispensed at home in application of article L. 5125-25 when the patient is unable to travel, in particular due to their state of health, age or particular geographical situation.

Read More »

Article R5125-51 of the French Public Health Code

Home dispensing may be carried out by the pharmacist holding or managing the pharmacy after death, or by the pharmacist managing the mutual benefit pharmacy or a mining relief society, or by their assistants or their replacements. It may also be carried out by the pharmacy assistants or students mentioned in article L. 4241-10. In the case mentioned in the previous paragraph, the pharmacist in charge or the pharmacist manager,…

Read More »

Article R5125-53 of the French Public Health Code

When dispensing a medicinal product or product other than that prescribed pursuant to article L. 5125-23, the pharmacist shall indicate on the prescription the name of the medicinal product or product dispensed, which, in the case of a proprietary medicinal product, is its name within the meaning of article R. 5121-1. He shall enter on the prescription the pharmaceutical form of the medicinal product dispensed if this differs from that…

Read More »

Article R5125-54 of the French Public Health Code

The express statement by which the prescriber excludes the possibility of substitution as provided for in the second paragraph of Article L. 5125-23 is as follows: “Non substitutable”. For prescriptions issued at the request of a patient for use in another Member State of the European Union, the statement provided for in the first paragraph is supplemented by a brief explanation of the reasons for excluding the possibility of substitution.

Read More »

Article R5125-55 of the French Public Health Code

Without prejudice to the provisions of Articles R. 5132-4 and R. 5132-29, a prescription expressed as a non-proprietary name pursuant to Article L. 5125-23 and as defined in Article R. 5121-1 must include at least : 1° The active ingredient of the medicinal product designated by its non-proprietary name ; 2° The strength of the active ingredient; 3° The route of administration and pharmaceutical form. If the medicinal product prescribed…

Read More »

Contact a French lawyer now

Contact a French Business Lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.